Classical lobular breast carcinoma consistently lacks topoisomerase-IIα gene amplification: implications for the tailored use of anthracycline-based chemotherapies-Reference-Cited by-同舟云学术

Classical lobular breast carcinoma consistently lacks topoisomerase-IIα gene amplification: implications for the tailored use of anthracycline-based chemotherapies

Published:2011-12-14 Issue:3 Volume:60 Page:482-488
ISSN:0309-0167
Container-title:Histopathology
language:en
Short-container-title:

Author:

Brunello Eleonora,Brunelli Matteo,Manfrin Erminia,Nottegar Alessia,Bersani Samantha,Vergine Marco,Molino Annamaria,Fiorio Elena,Chilosi Marco,Gobbo Stefano,Martignoni Guido,Bonetti Franco

Publisher

Wiley

Subject

General Medicine,Histology,Pathology and Forensic Medicine

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/j.1365-2559.2011.04067.x/fullpdf

Reference26 articles.

1. Are HER2 and TOP2A useful as prognostic or predictive biomarkers for anthracycline-based adjuvant chemotherapy for breast cancer?;Pritchard;J. Clin. Oncol.,2009

2. Topoisomerase II alpha and responsiveness of breast cancer to adjuvant chemotherapy;O’Malley;J. Natl Cancer Inst.,2009

3. Optimizing the delivery of targeted research: an opportunity for comparative effectiveness research;Pritchard;J. Clin. Oncol.,2010

4. HER-2 and topoisomerase II as predictors of response to chemotherapy;Pritchard;J. Clin. Oncol.,2008

5. Topoisomerase IIalpha gene amplification predicts favorable treatment response to tailored and dose-escalated anthracycline-based adjuvant chemotherapy in HER-2/neu-amplified breast cancer: Scandinavian Breast Group Trial 9401;Tanner;J. Clin. Oncol.,2006

Cited by 11 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Invasive Lobular Breast Cancer as a Distinct Disease: Implications for Therapeutic Strategy;Oncology and Therapy;2019-12-24

2. The role of histological subtype in hormone receptor positive metastatic breast cancer: similar survival but different therapeutic approaches;Oncotarget;2016-04-19

3. Comprehensive molecular portrait using next generation sequencing of resected intestinal-type gastric cancer patients dichotomized according to prognosis;Scientific Reports;2016-03

4. Issues Affecting the Loco-regional and Systemic Management of Patients with Invasive Lobular Carcinoma of the Breast;The Breast Journal;2016-01

5. Lobular breast cancers lack the inverse relationship between ER/PR status and cell growth rate characteristic of ductal cancers in two independent patient cohorts: implications for tumor biology and adjuvant therapy;BMC Cancer;2014-11-10